299 related articles for article (PubMed ID: 21112201)
21. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs).
Collison KS; Parhar RS; Saleh SS; Meyer BF; Kwaasi AA; Hammami MM; Schmidt AM; Stern DM; Al-Mohanna FA
J Leukoc Biol; 2002 Mar; 71(3):433-44. PubMed ID: 11867681
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies.
Daroux M; Prévost G; Maillard-Lefebvre H; Gaxatte C; D'Agati VD; Schmidt AM; Boulanger E
Diabetes Metab; 2010 Feb; 36(1):1-10. PubMed ID: 19932633
[TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus.
Lim M; Park L; Shin G; Hong H; Kang I; Park Y
Ann N Y Acad Sci; 2008 Dec; 1150():311-5. PubMed ID: 19120318
[TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.
Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS
Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180
[TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
26. Methylglyoxal: possible link between hyperglycaemia and immune suppression?
Price CL; Knight SC
Trends Endocrinol Metab; 2009 Sep; 20(7):312-7. PubMed ID: 19709901
[TBL] [Abstract][Full Text] [Related]
27. Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes.
Xanthis A; Hatzitolios A; Fidani S; Befani C; Giannakoulas G; Koliakos G
Angiology; 2009 Dec-2010 Jan; 60(6):772-9. PubMed ID: 19190027
[TBL] [Abstract][Full Text] [Related]
28. Receptor for advanced glycation end products and age-related macular degeneration.
Howes KA; Liu Y; Dunaief JL; Milam A; Frederick JM; Marks A; Baehr W
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3713-20. PubMed ID: 15452081
[TBL] [Abstract][Full Text] [Related]
29. Advanced glycation end product homeostasis: exogenous oxidants and innate defenses.
Vlassara H; Uribarri J; Cai W; Striker G
Ann N Y Acad Sci; 2008 Apr; 1126():46-52. PubMed ID: 18448795
[TBL] [Abstract][Full Text] [Related]
30. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical distribution of advanced glycation end products (AGEs) in human osteoarthritic cartilage.
Hirose J; Yamabe S; Takada K; Okamoto N; Nagai R; Mizuta H
Acta Histochem; 2011 Oct; 113(6):613-8. PubMed ID: 20656335
[TBL] [Abstract][Full Text] [Related]
32. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation endproducts and their receptor in different body compartments in COPD.
Hoonhorst SJ; Lo Tam Loi AT; Pouwels SD; Faiz A; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; van Oosterhout AJ; Lodewijk ME; Timens W; Postma DS; Ten Hacken NH
Respir Res; 2016 Apr; 17():46. PubMed ID: 27117828
[TBL] [Abstract][Full Text] [Related]
35. Pigment epithelium-derived factor (PEDF) blocks advanced glycation end products (AGEs)-RAGE-induced suppression of adiponectin mRNA level in adipocytes by inhibiting NADPH oxidase-mediated oxidative stress generation.
Maeda S; Matsui T; Takeuchi M; Yamagishi S
Int J Cardiol; 2011 Nov; 152(3):408-10. PubMed ID: 21911269
[No Abstract] [Full Text] [Related]
36. An update on advanced glycation endproducts and atherosclerosis.
Del Turco S; Basta G
Biofactors; 2012; 38(4):266-74. PubMed ID: 22488968
[TBL] [Abstract][Full Text] [Related]
37. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress.
Vincent AM; Perrone L; Sullivan KA; Backus C; Sastry AM; Lastoskie C; Feldman EL
Endocrinology; 2007 Feb; 148(2):548-58. PubMed ID: 17095586
[TBL] [Abstract][Full Text] [Related]
38. Urinary biomarkers of oxidative/nitrosative stress in healthy smokers.
Campos C; Guzmán R; López-Fernández E; Casado Á
Inhal Toxicol; 2011 Feb; 23(3):148-56. PubMed ID: 21391783
[TBL] [Abstract][Full Text] [Related]
39. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Ohlmeier S; Mazur W; Salmenkivi K; Myllärniemi M; Bergmann U; Kinnula VL
Proteomics Clin Appl; 2010 Jan; 4(1):97-105. PubMed ID: 21137019
[TBL] [Abstract][Full Text] [Related]
40. The interplay between hyperglycemia-induced oxidative stress markers and the level of soluble receptor for advanced glycation end products (sRAGE) in K562 cells.
Shemirani F; Yazdanparast R
Mol Cell Endocrinol; 2014 Aug; 393(1-2):179-86. PubMed ID: 24911882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
